Pavisi InnoCare and Meducation K hosted the 3rd Retigen Live Seminar on October 23.
Retigen is a high-purity atelocollagen product from which telopeptides, which can induce immune responses, have been removed. Lecturer Dr. Kim Min-seung described it as "a true anti-aging solution that directly acts on human tissue to activate the skin's inherent regenerative capabilities."
By removing impurities, it maintains a transparent formulation, offering high safety and immediate elasticity improvement when injected into the dermal layer.
Team Leader Yoon Sun-young stated that since its launch in 2023, Retigen has gained trust through numerous clinical data and is establishing itself as a new standard in anti-aging regenerative medicine.
Source: Money Today